AstraZeneca aims to transform outcomes for patients with hematologic malignancies.
Base: $270,221 - $405,332; Bonus/Equity: Not specified; Benefits: Health benefits including medical, dental, and vision coverage
Must-have
Nice-to-have
Not specified